Trademark Overview
On Tuesday, June 24, 2025, a trademark application was filed for POVTENZI with the United States Patent and Trademark Office. The USPTO has given the POVTENZI trademark a serial number of 99250865. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, August 19, 2025. This trademark is owned by Vertex Pharmaceuticals Incorporated. The POVTENZI trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of immunoglobulin A nephropathy; pharmaceutical preparations for the treatment of primary membranous nephropathy; pharmaceutical preparations for the treatment of lupus nephritis; pharmaceutical preparations for the treatment of renal anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis; pharmaceutical preparations for the treatment of immune thrombocytopenia; pharmaceutical preparations for the treatment of immune thrombocytopenia purpura; pharmaceutical preparations for the treatment of cold autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of warm autoimmune hemolytic anemia; pharmaceutical preparations for the treatment of kidney diseases and disorders; pharmaceutical preparations for the treatment of blood diseases and dis...
